Rosen Law Firm Encourages Sportradar Group AG Investors to Inquire About Securities Class Action Investigation - SRAD
NEW YORK, May 5, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announ…
prnewswire.com
OMCL(OMCL)
OMCL
Next earnings: Jul 30, 2026 · Before open
Signal
Leaning Bullish1↑
PRICE
Prev Close
43.44
Open
43.61
Day Range42.82 – 44.45
42.82
44.45
52W Range22.66 – 55.00
22.66
55.00
65% of range
VOLUME & SIZE
Avg Volume
883.8K
FUNDAMENTALS
P/E Ratio
96.8x
Premium valuation
EPS (TTM)
—
Div Yield
No dividend
Beta
0.97
Market-like
Performance
1D
+0.28%5D
+1.89%1M
+27.70%3M
+11.46%6M
+21.88%YTD↓
-3.84%1Y↑
+42.87%Best: 1Y (+42.87%)Worst: YTD (-3.84%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +8% YoY · 43% gross marginValuation
EXPENSIVE
P/E 97x vs ~20x sectorHealth
STRONG
CR 1.5 · FCF $2.47/shBullish
Key MetricsTTM
Market Cap$1.98B
Revenue TTM$1.23B
Net Income TTM$20.43M
Free Cash Flow$111.77M
Gross Margin43.5%
Net Margin1.7%
Operating Margin2.8%
Return on Equity1.6%
Return on Assets1.0%
Debt / Equity0.02
Current Ratio1.50
EPS TTM$0.45
Alpha SignalsFull Analysis →
What Moves This Stock
Hospital capital equipment spending trends - influenced by Medicare reimbursement rates, hospital operating margins, and elective procedure volumes
Recurring revenue growth rate and mix shift toward software subscriptions (target 40%+ of revenue)
New product adoption: Autonomous mobile robots for medication delivery, cloud-based central pharmacy management systems
Large enterprise contract wins with integrated delivery networks (IDNs) and group purchasing organizations (GPOs)
Macro Sensitivity
Economic Cycle
moderate - Hospital capital spending exhibits cyclical characteristics tied to patient volumes, elective procedures, and healthcare system profitability. Economic downturns reduce hospital operating margins, delaying discretionary automation projects. However, labor shortages and medication safety regulations provide structural demand support. Estimated 60-70% correlation with healthcare capital equipment spending cycles.
Interest Rates
Rising rates negatively impact Omnicell through two channels: (1) Higher cost of capital for hospital customers delays large automation projects with 3-5 year payback periods, and (2) SaaS valuation multiples compress as discount rates rise. Customer financing programs become less attractive in high-rate environments. However, minimal direct debt burden (0.18x D/E) limits balance sheet impact.
Key Risks
Technology disruption from cloud-native competitors or EHR vendors (Epic, Cerner/Oracle) vertically integrating medication management into core platforms
Medicare reimbursement cuts or hospital margin compression reducing capital budgets for automation investments
Regulatory changes to pharmacy benefit management or drug pricing affecting retail pharmacy medication adherence segment demand
Investor Profile
growth - Investors focus on recurring revenue transition story and long-term margin expansion potential from 0.4% to mid-teens operating margins. Current valuation (1.4x P/S, 19x EV/EBITDA) reflects growth expectations despite near-term profitability challenges. Turnaround/special situations investors attracted by depressed valuation following 83% earnings decline.
Watch on Earnings
Hospital capital equipment spending index and healthcare system operating marginsRecurring revenue growth rate and percentage of total revenue (target 40%+)Federal funds rate and 10-year Treasury yield (impacts customer financing decisions and valuation multiples)Medicare hospital reimbursement rate changes (affects customer budgets)
Health Radar
2 strong2 watch2 concern
48/100Liquidity
1.50Watch
Leverage
0.02Strong
Coverage
9.7xStrong
ROE
1.6%Concern
ROIC
1.2%Concern
Cash
$197MWatch
ANALYST COVERAGE19 analysts
HOLD
▲ +26.3%upside to target
L $49.00
Med $55.00consensus
H $70.00Stock Health
Composite Score
2 of 5 signals bullish
5/10
Technicals
●
✓RSI RangeRSI 52 — Bullish momentum
Volume
●
✗Volume FlowDistribution — institutional selling
Fundamentals
●
✓Last EarningsBeat estimates
●
~Analyst ConsensusHold
●
~LiquidityCurrent Ratio 1.50
Upcoming Events
EEarnings Report · Before OpenMay 7, 2026
Tomorrow
DEx-Dividend DateAug 4, 2026
In 90 days
PDividend PaymentAug 13, 2026
In 99 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
→ PullbackGolden Cross · 50D leads 200D by 26.9%
-2.9% vs SMA 50 · +23.3% vs SMA 200
Momentum
RSI51.7Neutral territory
MACD-0.75Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$55.00+26.3%
Current
$43.56
EMA 50
$42.27-3.0%
EMA 200
$35.82-17.8%
52W Low
$22.66-48.0%
52-Week RangeMid-range
$22.6665th %ile$55.00
Squeeze SetupVolume-based
Distribution PressureDistribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.
20-Day Money Flow
Acc days:2
Dist days:2
Edge:Even
Volume Context
Avg Vol (50D)538K
Recent Vol (5D)
547K+2%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 6 analysts
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $1.1B $1.1B–$1.1B | — | -$0.46 | — | ±2% | High5 |
FY2024 | $1.1B $1.1B–$1.1B | ▲ +2.3% | $1.69 | — | ±2% | High6 |
FY2025 | $1.2B $1.2B–$1.2B | ▲ +7.1% | $1.72 | ▲ +1.6% | ±1% | High6 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryOMCL
Last 8Q
+57.7%avg beat
Beat 7 of 8 quartersMissed 1↑ Estimates rising+219%
Q3'24
+37%
Q4'24
+5%
Q1'25
+63%
Q2'25
+45%
Q3'25
+42%
Q4'25
-15%
Q1'26
+67%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →No recent activity
KeyBancSector Weight → Overweight
Jan 7
UPGRADE
Wells FargoEqual-Weight → Overweight
May 14
UPGRADE
BarclaysEqual-Weight
Aug 2
UPGRADE
Piper SandlerOverweight
Nov 2
UPGRADE
BenchmarkBuy
Feb 27
UPGRADE
Insider Activity
SEC Filings →0 Buys/6 SellsNet Selling
Manley Corey JEVP&CHIEF LEGA…
$257K
Mar 16
SELL
Manley Corey JEVP&CHIEF LEGA…
$155K
Feb 17
SELL
Manley Corey JEVP&CHIEF LEGA…
$305K
Jan 8
SELL
Manley Corey JEVP&CHIEF LEGA…
$12K
Dec 16
SELL
Manley Corey JEVP&CHIEF LEGA…
$244K
Dec 3
SELL
Lipps Randall ADir
$1.0M
Dec 1
SELL
Financials
INSTITUTIONAL OWNERSHIP
1
Sumitomo Mitsui Trust Holdings, Inc.
1.4M▲2
Nuveen, LLC
389K▼3
PRINCIPAL FINANCIAL GROUP INC
296K▲4
BURNEY CO/
213K▲5
PEREGRINE CAPITAL MANAGEMENT LLC
135K▲6
STRS OHIO
120K▼7
Avory & Company, LLC
77K▼8
NEW YORK STATE TEACHERS RETIREMENT SYSTEM
54K▼News & Activity
OMCL News
20 articles · 4h ago
TrueBlue, Inc. (TBI) Q1 2026 Earnings Call Transcript
seekingalpha.com
DENTSPLY SIRONA Inc. (XRAY) Q1 2026 Earnings Call Transcript
seekingalpha.com
Energy Vault Holdings, Inc. (NRGV) Q1 2026 Earnings Call Transcript
seekingalpha.com
Blue Owl's Stack to consider $30 billion sale of Asia operations, Bloomberg News reports
reuters.com
LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit First Filed by the Firm
prnewswire.com
Avalo Therapeutics Announces Pricing of $375 Million Public Offering
globenewswire.com
DoorDash: Clear Opportunity Ahead Of Q1 Results
seekingalpha.com
American Coastal Insurance Corporation (ACIC) Q1 2026 Earnings Call Transcript
seekingalpha.com
Veeco Instruments Inc. (VECO) Q1 2026 Earnings Call Transcript
seekingalpha.com
Myriad Genetics, Inc. (MYGN) Q1 2026 Earnings Call Transcript
seekingalpha.com
Microsoft's AI Engine Is Already Running Ahead
seekingalpha.com
Samsung hits $1 trillion: what's behind the 10% surge in one day?
invezz.com
Hercules Capital, Inc. (HTGC) Q1 2026 Earnings Call Transcript
seekingalpha.com
Entergy Corporation announces pricing of common stock offering with a forward component
prnewswire.com
Tempus AI, Inc. (TEM) Q1 2026 Earnings Call Transcript
seekingalpha.com
loanDepot, Inc. (LDI) Q1 2026 Earnings Call Transcript
seekingalpha.com
Workato Launches Otto, the Trusted AI Teammate that Gets Work Done
businesswire.com
Whitbread plc (WTBDY) Q4 2026 Earnings Call Transcript
seekingalpha.com
Lumentum Holdings Inc. (LITE) Q3 2026 Earnings Call Transcript
seekingalpha.com
About
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Sector
Industry
Surgical and Medical Instrument Manufacturing
CEO
Randall Lipps
Website
Perry A. GenovaSenior Vice President & Chief Technology Officer
Dave FordSenior Vice President & Chief People Officer
Kathleen NemethSenior Vice President of Investor Relations
Peers— Health Care(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
OMCL◀ | $43.56 | +0.28% | $2.0B | 96.6 | +652.8% | 17.3% | 1500 |
| $68.78 | -0.30% | $13.3B | — | +12626.1% | -14525.8% | 1500 | |
| $89.52 | -1.81% | $11.7B | — | +3288.2% | -4239.0% | 1500 | |
| $502.47 | -3.12% | $11.5B | — | +43205.3% | -3008.0% | 1500 | |
| $223.06 | -0.29% | $11.4B | — | +6554.5% | -2868.8% | 1500 | |
| $74.93 | -1.91% | $10.5B | 51.9 | +2325815.3% | -19.7% | 1500 | |
| $175.95 | -3.34% | $10.3B | 28.0 | +1871.5% | 680.1% | 1500 | |
| Sector avg | — | -1.50% | — | 58.8 | +342002.0% | -3423.4% | 1500 |